Stefan, V.E.; Klepsch, V.; Thuille, N.; Steinlechner, M.; Peer, S.; Siegmund, K.; Lackner, P.; Schmutzhard, E.; Albrecht-Schgör, K.; Baier, G.
NR2F6 as a Disease Driver and Candidate Therapeutic Target in Experimental Cerebral Malaria. Cells 2025, 14, 1162.
https://doi.org/10.3390/cells14151162
AMA Style
Stefan VE, Klepsch V, Thuille N, Steinlechner M, Peer S, Siegmund K, Lackner P, Schmutzhard E, Albrecht-Schgör K, Baier G.
NR2F6 as a Disease Driver and Candidate Therapeutic Target in Experimental Cerebral Malaria. Cells. 2025; 14(15):1162.
https://doi.org/10.3390/cells14151162
Chicago/Turabian Style
Stefan, Victoria E., Victoria Klepsch, Nikolaus Thuille, Martina Steinlechner, Sebastian Peer, Kerstin Siegmund, Peter Lackner, Erich Schmutzhard, Karin Albrecht-Schgör, and Gottfried Baier.
2025. "NR2F6 as a Disease Driver and Candidate Therapeutic Target in Experimental Cerebral Malaria" Cells 14, no. 15: 1162.
https://doi.org/10.3390/cells14151162
APA Style
Stefan, V. E., Klepsch, V., Thuille, N., Steinlechner, M., Peer, S., Siegmund, K., Lackner, P., Schmutzhard, E., Albrecht-Schgör, K., & Baier, G.
(2025). NR2F6 as a Disease Driver and Candidate Therapeutic Target in Experimental Cerebral Malaria. Cells, 14(15), 1162.
https://doi.org/10.3390/cells14151162
